| Company Name: |
ShangHai Movin Pharmaceutical Co., Ltd.
|
| Tel: |
13681854265 |
| Email: |
info@moenpharm.com |
| Products Intro: |
Product Name:N-[(4-chloro-2-methylphenyl)methyl]-1-(4-chlorophenyl)-N-[(5-nitrothiophen-2-yl)methyl]methanamine Purity:0.97 Package:10g;100g;1kg
|
| Company Name: |
Energy Chemical
|
| Tel: |
021-58432009 400-005-6266 |
| Email: |
marketing@energy-chemical.com |
| Products Intro: |
Product Name:GSK 2945 CAS:1438071-12-5 Purity:NULL Package:100mg;10mg Remarks:NULL
|
N-[(4-chloro-2-methylphenyl)methyl]-1-(4-chlorophenyl)-N-[(5-nitrothiophen-2-yl)methyl]methanamine manufacturers
- GSK2945
-
- $1520.00
-
2026-05-11
- CAS:1438071-12-5
- Purity:
- Supply Ability: 10g
- GSK2945
-
- $1520.00
-
2025-07-17
- CAS:1438071-12-5
- Purity:
- Supply Ability: 10g
|
| | N-[(4-chloro-2-methylphenyl)methyl]-1-(4-chlorophenyl)-N-[(5-nitrothiophen-2-yl)methyl]methanamine Basic information |
| | N-[(4-chloro-2-methylphenyl)methyl]-1-(4-chlorophenyl)-N-[(5-nitrothiophen-2-yl)methyl]methanamine Chemical Properties |
| Boiling point | 525.0±45.0 °C(Predicted) | | density | 1.363±0.06 g/cm3(Predicted) | | solubility | Acetonitrile (Slightly), DMSO (Slightly, Heated), Methanol (Slightly, Sonicated) | | pka | 5.23±0.50(Predicted) | | form | Solid | | color | Off-White to Light Beige | | Stability: | Hygroscopic |
| | N-[(4-chloro-2-methylphenyl)methyl]-1-(4-chlorophenyl)-N-[(5-nitrothiophen-2-yl)methyl]methanamine Usage And Synthesis |
| Uses | GSK 2945 is an antagonist with high specificity for REV-ERBα, Nuclear heme receptor reverse erythroblastosis virus, which is known to regulate circadian rhythm and more specifically, regulation of cholesterol 7α-hydroxylase (CYP7A1) and bile acid synthesis. | | in vivo | GSK2945 (0-10 mg/kg; intraperitoneal injection; twice every day; for 7 days; male C57BL/6 mice) treatment increases hepatic mouse cholesterol 7α-hydroxylase (Cyp7a1) level and lowers plasma cholesterol in wild-type mice[1]. | Animal Model: | Male C57BL/6 mice (8-10 weeks of age)[1] | | Dosage: |
0 mg/kg or 10 mg/kg | | Administration: | Intraperitoneal injection; twice every day; for 7 days | | Result: | Increased hepatic mouse cholesterol 7α-hydroxylase (Cyp7a1) level and lowered plasma cholesterol in wild-type mice.
|
|
| | N-[(4-chloro-2-methylphenyl)methyl]-1-(4-chlorophenyl)-N-[(5-nitrothiophen-2-yl)methyl]methanamine Preparation Products And Raw materials |
|